Remedium Bio is a Boston based gene therapy company focused on the development of highly innovative treatments for a broad range of diseases. The Remedium approach utilizes proven scientific fundamentals, in a novel way, to treat the most debilitating conditions. Starting with well-characterized pathophysiological principles, our scientists modularly apply proven technologies to quickly advance curative treatments through the R&D cycle. Today, our leading candidates include gene therapy treatments in the fields of Endocrinology, Cardiology, Hematology, and Rheumatology.
Location: United States, Massachusetts, Needham
Member count: 1-10
Total raised: $2.3M
Founded date: 2020
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
16.08.2022 | Seed | $2.3M | - | finsmes.co... |
Mentions in press and media 2
Date | Title | Description | Category | Author | Source |
16.08.2022 | Remedium B... | Remedium Bio, a Boston, MA-bas... | USA | - | finsmes.co... |
15.09.2021 | Remedium B... | BOSTON, Sept. 15, 2021 /PRNe... | - | - | prnewswire... |